| pubmed-article:9233868 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0001175 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0019693 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0041296 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0008972 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0009462 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0022209 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0221117 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0376691 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C1547564 | lld:lifeskim |
| pubmed-article:9233868 | lifeskim:mentions | umls-concept:C0449435 | lld:lifeskim |
| pubmed-article:9233868 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9233868 | pubmed:dateCreated | 1997-7-31 | lld:pubmed |
| pubmed-article:9233868 | pubmed:abstractText | Patients with human immunodeficiency virus (HIV) infection and latent tuberculosis are at substantial risk for the development of active tuberculosis. As a public health measure, prophylactic treatment with isoniazid has been suggested for HIV-infected persons who have anergy and are in groups with a high prevalence of tuberculosis. | lld:pubmed |
| pubmed-article:9233868 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9233868 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9233868 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9233868 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9233868 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9233868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9233868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9233868 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9233868 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9233868 | pubmed:issn | 0028-4793 | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:PerezGG | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:KleinMM | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:SzaboSS | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:MillerCC | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:MattsJ PJP | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:VaughnAA | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:BrownL SLS | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:JohnS LSL | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:GordinF MFM | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:HafnerRR | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:BeschC LCL | lld:pubmed |
| pubmed-article:9233868 | pubmed:author | pubmed-author:El-SadrWW | lld:pubmed |
| pubmed-article:9233868 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9233868 | pubmed:day | 31 | lld:pubmed |
| pubmed-article:9233868 | pubmed:volume | 337 | lld:pubmed |
| pubmed-article:9233868 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9233868 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9233868 | pubmed:pagination | 315-20 | lld:pubmed |
| pubmed-article:9233868 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:meshHeading | pubmed-meshheading:9233868-... | lld:pubmed |
| pubmed-article:9233868 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9233868 | pubmed:articleTitle | A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. | lld:pubmed |
| pubmed-article:9233868 | pubmed:affiliation | Medical Service, Veterans Affairs Medical Center, and Georgetown University, Washington, D.C. 20422, USA. | lld:pubmed |
| pubmed-article:9233868 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9233868 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9233868 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9233868 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9233868 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9233868 | lld:pubmed |
